A detailed history of Twin Lakes Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 5,738 shares of BMY stock, worth $311,688. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,738
Previous 7,063 18.76%
Holding current value
$311,688
Previous $383,000 37.86%
% of portfolio
0.17%
Previous 0.26%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $53,331 - $70,211
-1,325 Reduced 18.76%
5,738 $238,000
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $3,982 - $4,515
83 Added 1.19%
7,063 $383,000
Q4 2023

Feb 08, 2024

BUY
$48.48 - $57.85 $3,635 - $4,338
75 Added 1.09%
6,980 $358,000
Q3 2023

Nov 16, 2023

BUY
$57.89 - $64.73 $3,531 - $3,948
61 Added 0.89%
6,905 $400,000
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $3,504 - $3,890
55 Added 0.81%
6,844 $437,000
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $3,416 - $3,875
52 Added 0.77%
6,789 $470,000
Q4 2022

Feb 03, 2023

BUY
$68.48 - $81.09 $3,150 - $3,730
46 Added 0.69%
6,737 $484,000
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $6 - $3,611
47 Added 0.71%
6,691 $476,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $26,869 - $29,592
-370 Reduced 5.28%
6,644 $512,000
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $8,053 - $9,657
131 Added 1.9%
7,014 $512,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $3,003 - $3,501
56 Added 0.82%
6,883 $429,000
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $1,124 - $1,316
-19 Reduced 0.28%
6,827 $404,000
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $15,477 - $16,855
-250 Reduced 3.52%
6,846 $457,000
Q1 2021

May 18, 2021

BUY
$59.34 - $66.74 $12,164 - $13,681
205 Added 2.97%
7,096 $448,000
Q4 2020

Feb 26, 2021

BUY
$57.74 - $65.43 $397,886 - $450,878
6,891 New
6,891 $427,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Twin Lakes Capital Management, LLC Portfolio

Follow Twin Lakes Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.